Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Cardiography|March 1, 1986
[Malignant familial cardiomyopathy with sudden death, typical asymmetric septal hypertrophy and dilated cardiomyopathy-like features]T Seo, Y Yokota, N Maehashi, et al.Journal of Cardiology|June 1, 1987
[Relationships between segmental left ventricular wall motion abnormalities and pathological findings in patients with dilated cardiomyopathy]N Maehashi, Y Yokota, A Takarada, et al.Journal of Cardiology|September 1, 1988
[Comparison of regional contractile dynamics and pathological findings of the left ventricular wall in patients with hypertrophic cardiomyopathy]S Usuki, Y Yokota, N Maehashi, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cellsM Baba, O Nakanishi, W Sato, et al.Journal of Cardiography|March 1, 1986
[Severity and non-uniformity of regional wall motion in dilated cardiomyopathy evaluated by two-dimensional echocardiography]A Takarada, Y Yokota, T Kumaki, et al.Journal of Cardiology|December 1, 1987
[A trial diagnosis of latent dilated cardiomyopathy]H Kurozumi, Y Yokota, T Miki, et al.Journal of Cardiology|December 1, 1987
[Pulsed Doppler echocardiographic findings in 117 professional cyclists]T Miki, Y Yokota, R Emoto, et al.Journal of Dental Research|February 12, 2013
Endothelin receptor-mediated responses in trigeminal ganglion neuronsT Yamamoto, K Ono, S Hitomi, et al.Oncology Research|January 1, 1997
Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell linesO Nakanishi, M Baba, A Saito, et al.Cancer Research|February 28, 2001
MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cellsB I Lee, S H Park, J W Kim, et al.Pageof 6